But while high-quality, long-term safety data is lacking for now, the WHO guideline provides clinicians with a comprehensive summary of evidence as it currently stands
This case study , published in 2023, describes three female patients taking semaglutide who visited their healthcare clinic due to severe mouth dryness, as well as minimal frothy saliva. After underlying medical problems were excluded (such as low water intake or a condition called Sjogrens disease) as the cause, the females were diagnosed with hyposalivation (dry mouth)
Zhang X, Selvaraju K, Saei AA, DArcy P, Zubarev RA, Arnr ES, et al
After a comprehensive consultation and health screening, your personalized weight loss plan begins with a low initial weekly dose of the injectable medication